Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-9-12
pubmed:abstractText
Our objective was to evaluate the influence of polymorphisms at codons 49 and 389 of the beta1-adrenergic receptor (beta1-AR) on the response to beta-blockers and outcome in patients with dilated cardiomyopathy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0009-9236
pubmed:author
pubmed:issnType
Print
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
221-31
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16153393-Adrenergic beta-Antagonists, pubmed-meshheading:16153393-Aged, pubmed-meshheading:16153393-Amino Acid Substitution, pubmed-meshheading:16153393-Cardiomyopathy, Dilated, pubmed-meshheading:16153393-Codon, pubmed-meshheading:16153393-Cohort Studies, pubmed-meshheading:16153393-DNA, pubmed-meshheading:16153393-Dose-Response Relationship, Drug, pubmed-meshheading:16153393-Female, pubmed-meshheading:16153393-Genotype, pubmed-meshheading:16153393-Glycine, pubmed-meshheading:16153393-Humans, pubmed-meshheading:16153393-Male, pubmed-meshheading:16153393-Middle Aged, pubmed-meshheading:16153393-Polymorphism, Genetic, pubmed-meshheading:16153393-Prospective Studies, pubmed-meshheading:16153393-Receptors, Adrenergic, beta-1, pubmed-meshheading:16153393-Serine, pubmed-meshheading:16153393-Survival Rate, pubmed-meshheading:16153393-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
pubmed:affiliation
Wallenberg Laboratory for Cardiovascular Research and Department of Primary Health Care, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. yvonne.magnusson@wlab.gu.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study